ESMO Chief Medical Officer
European Society for Medical Oncology
Jean-Yves Douillard received his medical training at the University of Nantes Medical School and completed his PhD in 1993. He was the recipient of a fellowship from the French Ministry of Health and the US National Institutes of Health John E. Fogarty International Center for Advanced Study in the Health Sciences.
He completed two years as a visiting Fellow at the National Cancer Institute’s Laboratory of Immunodiagnosis, before returning to France to accept the position of Assistant Professor in Medical Oncology at the University of Nantes. He spent a further two years as a visiting scientist at the US Food and Drug Administration Center for Biologics Evaluation and Research at the National Institute of Health, Bethesda and Rockville, MD, USA. Previously, he was Head of the Department of Medical Oncology (2000–2009) and Director of Clinical and Translational Research (2009–2011) at the Integrated Centres of Oncology R. Gauducheau, and then was Professor of Medical Oncology and Senior Staff Physician at the Integrated Centres of Oncology R. Gauducheau and the University of Nantes Medical School, Nantes, France.
His clinical trial involvement focuses mainly on lung cancer and gastrointestinal tumours, and has included investigations of several new drugs, as well as targeted therapies.
He was a member of the Editorial Boards of the Journal of Clinical Oncology and Bulletin du Cancer. He currently serves on the Editorial Board of Hybridoma and is the Associate Editor of Clinical Colorectal Cancer and ESMO Open journal. In March 2016 he was appointed ESMO's first Chief Medical Officer. He is also an ESMO member.
He is a member of the American Society of Clinical Oncology, the International Association for the Study of Lung Cancer, the American Association for Cancer Research and the French Co-Operative Thoracic Intergroup. He has published numerous articles in prestigious scientific journals, including The Lancet, the New England Journal of Medicine, the Journal of Clinical Oncology, The Lancet Oncology, the British Journal of Cancer, Cancer Research, the European Journal of Cancer, Annals of Oncology and the Journal of Thoracic Oncology.